Indeed, it has been demonstrated that inhibition of Agt in hepatocytes using genetic and pharmacological manipulations can profoundly reduce systolic blood pressure and atherosclerosis, and Agt exerts its effects independently of angiotensin II18. The gene discussed is AGT; the disease is atherosclerosis.